SEC Form 4 · accession 0001579618-15-000002
ANI PHARMACEUTICALS INC · ANIP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Tracy Marshbanks
Director
Period of report
Apr 16, 2015
Accepted (ET)
Apr 20, 2015 · 5:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001023024
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 16, 2015 | A | 800 | $0.00 | A | 9,110 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to PurchaseF2 | $68.71 | Apr 16, 2015 | A | 1,600 | A | Apr 16, 2016 | Apr 15, 2025 | Common Stock | 1,600 | 1,600 | D |
Explanation of responses
- F1On April 16, 2015, the Board of Directors of the Issuer approved the grant of restricted stock, which vest on the first anniversary of the grant date.
- F2The closing price of the Issuer's common stock on the NASDAQ Global Market on the grant date.